Return-Path: <john.podesta@gmail.com>
Received: from [192.168.1.2] (pool-108-45-53-96.washdc.fios.verizon.net. [108.45.53.96])
        by mx.google.com with ESMTPSA id w7sm12032527qge.17.2014.11.08.17.31.55
        for <multiple recipients>
        (version=TLSv1 cipher=ECDHE-RSA-RC4-SHA bits=128/128);
        Sat, 08 Nov 2014 17:31:55 -0800 (PST)
References: <50f412b363f24b768f498acf1e525527@BN1PR07MB152.namprd07.prod.outlook.com>
Mime-Version: 1.0 (1.0)
In-Reply-To: <50f412b363f24b768f498acf1e525527@BN1PR07MB152.namprd07.prod.outlook.com>
Content-Type: text/plain;
	charset=us-ascii
Content-Transfer-Encoding: quoted-printable
Message-Id: <C28753BE-B311-4A95-B037-EF4612A6DB34@gmail.com>
CC: Eryn Sepp <Eryn_M_Sepp@who.eop.gov>
X-Mailer: iPad Mail (11B554a)
From: John Podesta <john.podesta@gmail.com>
Subject: Re: 
Date: Sat, 8 Nov 2014 20:31:54 -0500
To: Doug Band <doug.band@teneoholdings.com>

Eryn will ck the schedule

JP
--Sent from my iPad--
john.podesta@gmail.com
For scheduling: eryn.sepp@gmail.com

> On Nov 8, 2014, at 7:49 PM, Doug Band <doug.band@teneoholdings.com> wrote:=

>=20
> Hope you are well
>=20
> Any interest in mtg with joe jimenez, ceo of novartis,  on December 1, any=
time from 1130am-430pm? CEO of largest pharma company in world, industry lea=
der in R&D, most FDA approvals than any in industry
>=20
> Good guy, novartis is a big client of ours
>=20
